Skip to main content

View full-text article in PMC

. 2008 Jul 23;47(9):1335–1341. doi: 10.1093/rheumatology/ken256

Table 1.

Clinical and laboratory characteristics of SLE patients at the time of blood draw

		Mean value					Percentage of patients								Percentage of patients
SLE subgroup	n	Age (yrs)	Disease activity score	ECLAM score	Anti-dsDNA (IU/ml)	Apoptosis (%PBMC)	Mucocu- taneous disease	Arthritis	Haematuria	Thrombocy- topenia	Lymphopenia	Hypocomple- mentemia	High PBMC apoptosis	High plasma IFN-α	IV methyl- prednisolone^a	IV cyclophos- phamide^a	Daily oral mycophenolate	Daily oral HCQ	Daily oral prednisone	Weekly oral MTX
Remission	14	14.7	1.6	1.8	52	30	43	7	9	0	15	46	0	0	21	7	7	79	57	14
Flare	12	13.8	5.2	3.5	312	61	36	36	22	17	50	83	83	29	8	8	0	75	58	25
P-value		NS	<2×10⁻⁷	<0.04	<0.05	<0.004	NS	NS	NS	NS	NS	NS	<0.01	NS	NS	NS	NS	NS	NS	NS

^aWithin 3 months.